Financials
- Market Capitalization 2.06 B
- Employee 562
- Founded 2012
- CEO Carl Hansen
- Website www.abcellera.com
- Headquarter British Columbia, Canada
- FIGI BBG00LLW2MF2
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1939 | OCUL Ocular Therapeutix, Inc. - Common Stock | 9.70 USD | -1.82% | -5.09% | +7.90% | -15.65% | 2.12 B USD | ||
| 1958 | ATAI AtaiBeckley Inc. - Common Stock | 5.67 USD | +14.08% | +10.96% | +47.66% | +43.54% | 2.09 B USD | ||
| 1969 | ADMA ADMA Biologics Inc - Common Stock | 8.87 USD | -1.11% | -1.55% | +4.97% | -50.72% | 2.06 B USD | ||
| 1970 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 15.98 USD | -0.31% | -0.62% | -0.62% | +33.95% | 2.06 B USD |
Frequently asked questions about AbCellera Biologics Inc. - Common Shares
What is the AbCellera Biologics Inc. - Common Shares stock price today?
The current price of AbCellera Biologics Inc. - Common Shares (ABCL) is 6.74. Over the past 24 hours, the stock has changed by +3.37%. Follow the ABCL chart for real-time price dynamics.
What is the stock ticker of AbCellera Biologics Inc. - Common Shares?
AbCellera Biologics Inc. - Common Shares trades under the ticker ABCL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is AbCellera Biologics Inc. - Common Shares stock going up?
ABCL has changed by -8.80% over the last week, +28.87% over the last month, and +69.77% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was AbCellera Biologics Inc. - Common Shares net income for the last quarter?
AbCellera Biologics Inc. - Common Shares reported net income of -43.16 M for the last quarter. The previous quarter showed -8.95 M, which means net income changed by -382.56%.
How many employees does AbCellera Biologics Inc. - Common Shares have?
As of the latest available data, AbCellera Biologics Inc. - Common Shares has 562 employees. Workforce size can provide additional context about the company's scale and operations.
What is AbCellera Biologics Inc. - Common Shares EBITDA?
AbCellera Biologics Inc. - Common Shares EBITDA is -50.68 M, and its EBITDA margin is -609.51%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy AbCellera Biologics Inc. - Common Shares stock?
You can buy AbCellera Biologics Inc. - Common Shares (ABCL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in AbCellera Biologics Inc. - Common Shares stock?
Investing in AbCellera Biologics Inc. - Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ABCL chart and related analysis on metatrader.com as part of your research.